MRI Radiomics and Machine Learning for the Prediction of Oncotype Dx Recurrence Score in Invasive Breast Cancer

被引:11
|
作者
Romeo, Valeria [1 ]
Cuocolo, Renato [2 ,3 ]
Sanduzzi, Luca [1 ]
Carpentiero, Vincenzo [1 ]
Caruso, Martina [1 ]
Lama, Beatrice [1 ]
Garifalos, Dimitri [1 ]
Stanzione, Arnaldo [1 ]
Maurea, Simone [1 ]
Brunetti, Arturo [1 ]
机构
[1] Univ Naples Federico II, Dept Adv Biomed Sci, I-80131 Naples, Italy
[2] Univ Salerno, Dept Med Surg & Dent, I-84084 Baronissi, Italy
[3] Univ Naples Federico II, Dept Elect Engn & Informat Technol, Augmented Real Hlth Monitoring Lab ARHeMLab, I-80131 Naples, Italy
关键词
radiomics; oncotype DX; breast cancer; machine learning; neoadjuvant chemotherapy; magnetic resonance; recurrence score; CHEMOTHERAPY; TAMOXIFEN; FEATURES; RISK;
D O I
10.3390/cancers15061840
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary The preoperative definition of the Oncotype DX recurrence score would be critical to identify breast cancer patients who could benefit from chemotherapy before surgery. In this work, we built a machine learning model applied to DCE-MRI images of a publicly available dataset to predict the Oncotype DX score in patients with breast cancer. As a result, the model achieved an accuracy of 60% in the training set and 63% (AUC = 0.66) in the test set. Our findings support the feasibility of radiomics and machine learning for the prediction of prognostic data in breast cancer, encouraging further, preferably multicenter, investigations to further improve the performance of the model and assess its generalizability. Aim: To non-invasively predict Oncotype DX recurrence scores (ODXRS) in patients with ER+ HER2- invasive breast cancer (IBC) using dynamic contrast-enhanced (DCE) MRI-derived radiomics features extracted from primary tumor lesions and a ML algorithm. Materials and Methods: Pre-operative DCE-MRI of patients with IBC, no history of neoadjuvant therapy prior to MRI, and for which the ODXRS was available, were retrospectively selected from a public dataset. ODXRS was obtained on histological tumor samples and considered as positive if greater than 16 and 26 in patients aged under and over 50 years, respectively. Tumor lesions were manually annotated by three independent operators on DCE-MRI images through 3D ROIs positioning. Radiomic features were therefore extracted and selected using multistep feature selection process. A logistic regression ML classifier was then employed for the prediction of ODXRS. Results: 248 patients were included, of which 87 with positive ODXRS. 166 (66%) patients were grouped in the training set, while 82 (33%) in the test set. A total of 1288 features was extracted. Of these, 1244 were excluded as 771, 82 and 391 were excluded as not stable (n = 771), not variant (n = 82), and highly intercorrelated (n = 391), respectively. After the use of recursive feature elimination with logistic regression estimator and polynomial transformation, 92 features were finally selected. In the training set, the logistic regression classifier obtained an overall mean accuracy of 60%. In the test set, the accuracy of the ML classifier was 63%, with a sensitivity of 80%, specificity of 43%, and AUC of 66%. Conclusions: Radiomics and ML applied to pre-operative DCE-MRI in patients with IBC showed promises for the non-invasive prediction of ODXRS, aiding in selecting patients who will benefit from NAC.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] ASO Visual Abstract: Discordance in Oncotype DX Breast Recurrence Score® Results for Bilateral Breast Cancer
    Bloom, Joshua A.
    Sekigami, Yurie
    Young, Rebekah
    Macera, Lisa
    Russell, Christy A.
    Cao, Yu
    Buchsbaum, Rachel J.
    Naber, Stephen P.
    Chatterjee, Abhishek
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 3) : 515 - 516
  • [42] The Relationship between Oncotype DX Recurrence Score, Clinicopathological Factors, and Molecular Classification in Breast Cancer
    Tang, P.
    Wang, J.
    Hicks, D. G.
    Wang, X.
    Schiffhauer, L.
    Shayne, M.
    Huston, A.
    Skinner, K.
    Griggs, J.
    Lyman, G.
    MODERN PATHOLOGY, 2009, 22 : 72A - 72A
  • [43] Oncotype DX Recurrence Score in premenopausal women
    Zhang, Shiliang
    Fitzsimmons, Kasey C.
    Hurvitz, Sara A.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [44] Impact of Oncotype DX Recurrence Score on Adjuvant Chemotherapy Recommendations in Young Patients with Breast Cancer
    Dodman, Keisha G.
    Williams, Austin D.
    De La Cruz, Lucy M.
    Tchou, Julia C.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2018, 227 (04) : E6 - E6
  • [45] Ki67 cut offs and oncotype DX recurrence score in early breast cancer
    Namuche, Fernando
    Ruiz, Rossana
    Flores, Claudio
    Gomez, Henry L.
    Aguilar, Alfredo
    CANCER RESEARCH, 2018, 78 (04)
  • [46] Distant Metastases in Breast Cancer Patients with Oncotype Dx Recurrence Score Lower Than 18
    Krystel-Whittemore, Melissa
    Brogi, Edi
    Bowser, Zenica L.
    Dickler, Maura
    Hudis, Clifford
    Wen, Hannah Y.
    LABORATORY INVESTIGATION, 2016, 96 : 52A - 52A
  • [47] The Relationship between Oncotype DX Recurrence Score, Clinicopathological Factors, and Molecular Classification in Breast Cancer
    Tang, P.
    Wang, J.
    Hicks, D. G.
    Wang, X.
    Schiffhauer, L.
    Shayne, M.
    Huston, A.
    Skinner, K.
    Griggs, J.
    Lyman, G.
    LABORATORY INVESTIGATION, 2009, 89 : 72A - 72A
  • [48] Association of exogenous hormone use with breast cancer subtype defined by Oncotype DX recurrence score
    Benefield, Halei
    Reeder-Hayes, Katherine
    Wheeler, Stephanie
    Carey, Lisa
    Olshan, Andrew
    Troester, Melissa
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 387 - 387
  • [49] Distant Metastases in Breast Cancer Patients with Oncotype Dx Recurrence Score Lower Than 18
    Krystel-Whittemore, Melissa
    Brogi, Edi
    Bowser, Zenica L.
    Dickler, Maura
    Hudis, Clifford
    Wen, Hannah Y.
    MODERN PATHOLOGY, 2016, 29 : 52A - 52A
  • [50] Comparison of Oncotype DX Breast Recurrence Score® Values from Repeat Testing of the Same Primary Invasive Breast Cancers
    Dadhania, Puja
    Tharayanil, Anson
    Braun, Jerome V.
    Peter, Samson
    Mies, Carolyn
    MODERN PATHOLOGY, 2018, 31 : 56 - 57